With a reported ROE near 4.1% in Q3 2026, the 1.73 times price-to-book multiple implies the market is pricing returns well below the peer group's 18.9% ROE for FBP, which warrants attention to whether the discount is structural or temporary. The price-to-tangible-book multiple of roughly 1.7 times sits against tangible book value per share near $29, and investors should monitor whether ROTCE can close the gap with FBP and BPOP, which together indicate the market rewards higher sustained returns on tangible equity. The 0.35 PEG suggests the earnings growth embedded in the price is modest relative to the multiple, but this metric alone cannot confirm whether the discount is justified.

The DuPont structure shows the return gap is driven by asset profitability rather than leverage, since the equity multiplier is conservative at roughly nine times and ROA sits near 0.5%. Net interest margin of about 1.3% is modest for a lender, and fee income rising to 17.5% of revenue provides some diversification, but the mix has not yet lifted ROA materially. Investors should interpret the stable ROE of 3.6% to 4.2% over ten quarters as evidence of consistent but limited profitability rather than a trend toward improvement.

The stable NIM indicates that funding cost advantages and asset yields have offset each other, leaving little room for spread expansion, which is consistent with the flat net interest income trajectory. The efficiency ratio volatility, rather than margin movement, appears to be the main source of operating leverage changes, suggesting expense timing or revenue mix shifts are doing the work. The data does not disclose deposit cost or beta, so the funding advantage underlying the NIM cannot be verified from the supplied information.

The steady equity ratio and tangible book value growth from roughly $24.8 to $29.4 per share over the period suggest retained earnings are building capital organically, consistent with dividend yields of 2.2% and buybacks that have varied. Without CET1 or total capital ratios against regulatory minimums, the analysis cannot confirm headroom for larger repurchases. Investors should obtain these regulatory ratios before inferring capacity for capital return.